JP2016527247A5 - - Google Patents

Download PDF

Info

Publication number
JP2016527247A5
JP2016527247A5 JP2016528615A JP2016528615A JP2016527247A5 JP 2016527247 A5 JP2016527247 A5 JP 2016527247A5 JP 2016528615 A JP2016528615 A JP 2016528615A JP 2016528615 A JP2016528615 A JP 2016528615A JP 2016527247 A5 JP2016527247 A5 JP 2016527247A5
Authority
JP
Japan
Prior art keywords
solvent
pancreatin
usp
organic solvent
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016528615A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016527247A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2014/002583 external-priority patent/WO2015019198A2/en
Publication of JP2016527247A publication Critical patent/JP2016527247A/ja
Publication of JP2016527247A5 publication Critical patent/JP2016527247A5/ja
Pending legal-status Critical Current

Links

JP2016528615A 2013-07-22 2014-07-15 高力価パンクレアチン医薬組成物 Pending JP2016527247A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361856952P 2013-07-22 2013-07-22
US61/856,952 2013-07-22
PCT/IB2014/002583 WO2015019198A2 (en) 2013-07-22 2014-07-15 High potency pancreatin pharmaceutical compositions

Publications (2)

Publication Number Publication Date
JP2016527247A JP2016527247A (ja) 2016-09-08
JP2016527247A5 true JP2016527247A5 (https=) 2017-07-13

Family

ID=52117920

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016528615A Pending JP2016527247A (ja) 2013-07-22 2014-07-15 高力価パンクレアチン医薬組成物

Country Status (13)

Country Link
US (2) US20160152968A1 (https=)
EP (1) EP3024479B2 (https=)
JP (1) JP2016527247A (https=)
KR (1) KR20160055123A (https=)
CN (1) CN105392496A (https=)
AU (1) AU2014304176A1 (https=)
BR (1) BR112016001289A2 (https=)
CA (1) CA2919114A1 (https=)
ES (1) ES2743212T5 (https=)
IL (1) IL243627A (https=)
MX (1) MX2016000794A (https=)
RU (1) RU2686460C2 (https=)
WO (1) WO2015019198A2 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1319655B1 (it) 2000-11-15 2003-10-23 Eurand Int Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione.
JP5966202B2 (ja) 2007-02-20 2016-08-10 アラガン ファーマシューティカルズ インターナショナル リミテッド 安定な消化酵素組成物
US10087493B2 (en) 2008-03-07 2018-10-02 Aptalis Pharma Canada Ulc Method for detecting infectious parvovirus in pharmaceutical preparations
ES2657673T3 (es) 2010-10-01 2018-03-06 Aptalis Pharma Limited Formulaciones recubiertas entéricas de pancrelipasa, de baja intensidad
CA2843556A1 (en) 2011-08-08 2013-02-14 Aptalis Pharma Ltd. Method for dissolution testing of solid compositions containing digestive enzymes
US10184121B2 (en) 2013-06-28 2019-01-22 Allergan Pharmaceuticals International Limited Methods for removing viral contaminants from pancreatic extracts
CA2920844A1 (en) 2013-08-09 2015-02-12 Allergan Pharmaceuticals International Limited Digestive enzyme composition suitable for enteral administration
EP3003360B1 (en) * 2013-11-05 2020-10-07 Allergan Pharmaceuticals International Limited High potency pancreatin pharmaceutical compositions
ES2970869T3 (es) * 2016-03-28 2024-05-31 Abbott Laboratories Gmbh Composiciones enzimáticas con contaminación vírica y microbiana reducida
US11278603B2 (en) 2016-03-28 2022-03-22 Abbvie Inc. Enzyme compositions with reduced viral and microbial contamination
US11291236B2 (en) * 2017-09-11 2022-04-05 Alcresta Therapeutics, Inc. Devices and methods for the preparation of a nutritional formula
BR112020006211A2 (pt) * 2017-09-27 2020-10-13 Abbott Laboratories Gmbh preparação de enzima produzida por um método, preparação de enzima, método para produzir um produto de pancreatina, composição farmacêutica e método para tratar insuficiência pancreática exócrina
CN111394275B (zh) * 2020-02-22 2022-05-27 华东师范大学 一株解淀粉芽孢杆菌及其应用、水产饲料和水产养殖方法
FR3111559A1 (fr) * 2020-06-18 2021-12-24 Azurrx Biopharma, Inc. Formulations non porcines et leurs procédés

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB928654A (en) 1960-10-25 1963-06-12 Philips Nv Improvements in or relating to the production of pancreatin
US3168448A (en) * 1963-01-07 1965-02-02 Wilson & Co Inc Process of preparing a lipolytic enzyme composition
DE3377506D1 (en) * 1982-12-30 1988-09-01 Nordmark Arzneimittel Gmbh Process for obtaining pancreatin
DK173590D0 (da) * 1990-06-06 1990-07-19 Novo Nordisk As Rekombinante terapeutiske lipaser
DE69634248T2 (de) 1995-05-31 2006-01-12 Medzyme N.V. Zusammensetzungen zur verbesserung der verdaulichkeit und ausnutzung von nähestoffen
KR19990072826A (ko) * 1998-02-26 1999-09-27 우재영 판크레아틴장용코팅과립의제조방법
US20010046493A1 (en) 2000-02-24 2001-11-29 Alex Margolin Lipase-containing composition and methods of use thereof
AR032392A1 (es) * 2001-01-19 2003-11-05 Solvay Pharm Gmbh Mezcla de enzimas, preparado farmaceutico y utilizacion de dicho preparado.
CA2419572A1 (en) * 2003-02-18 2004-08-18 Axcan Pharma Inc. High dosage protease formulation
US20060198838A1 (en) * 2004-09-28 2006-09-07 Fallon Joan M Combination enzyme for cystic fibrosis
WO2006044529A1 (en) 2004-10-14 2006-04-27 Altus Pharmaceuticals Inc. Compositions containing lipase; protease and amylase for treating pancreatic insufficiency
RU2445952C2 (ru) * 2007-02-20 2012-03-27 Юранд Фармасьютикалз Лимитед Стабильные композиции пищеварительных ферментов
BR112012023517A2 (pt) * 2010-03-19 2017-10-03 Aptalis Pharma Canada Inc Preparação de enzima pancreática (pep) tendo infectividade viral reduzida, composição farmacêutica tendo infectividade viral reduzida, forma de dosagem oral sólida, método para tratar insuficiência pancreática em um paciente que necessita disso e método para preparar um apreparação de enzima pancreática (pep)
CA2843556A1 (en) * 2011-08-08 2013-02-14 Aptalis Pharma Ltd. Method for dissolution testing of solid compositions containing digestive enzymes
JP2013071929A (ja) * 2011-09-29 2013-04-22 Kobayashi Pharmaceutical Co Ltd 胃腸薬
CA2920844A1 (en) * 2013-08-09 2015-02-12 Allergan Pharmaceuticals International Limited Digestive enzyme composition suitable for enteral administration
EP3003360B1 (en) 2013-11-05 2020-10-07 Allergan Pharmaceuticals International Limited High potency pancreatin pharmaceutical compositions

Similar Documents

Publication Publication Date Title
JP2016527247A5 (https=)
RU2686460C2 (ru) Высокоэффективные фармацевтические композиции панкреатина
Ali et al. Recovery and partial purification of fibrinolytic enzymes of Auricularia polytricha (Mont.) Sacc by an aqueous two-phase system
CN106659773A (zh) 高效的胰酶药物组合物
US10184121B2 (en) Methods for removing viral contaminants from pancreatic extracts
JP6109881B2 (ja) 固体含有生物抽出物のウイルスおよび微生物含有量を低減する方法
JP2020531627A (ja) チュウゴクオオサンショウウオ軟骨製剤
WO2010034176A1 (zh) 来自尖吻蝮蛇的类凝血酶
Yarong et al. Paeonol reduces microbial metabolite α-hydroxyisobutyric acid to alleviate the ROS/TXNIP/NLRP3 pathway-mediated endothelial inflammation in atherosclerosis mice
Lozano-Ojalvo et al. Hypoallergenic hydrolysates of egg white proteins modulate allergen responses induced ex vivo on spleen cells from sensitized mice
US4645667A (en) Antitumor agent and process for manufacturing said agent
US9676817B2 (en) Method for the removal of virus from a protein solution
CN106879884B (zh) 一种提高蜂王浆性能的方法
US20200255817A1 (en) High potency pancreatin pharmaceutical compositions
CN110218717B (zh) 一种灵芝多糖的制备方法及其对超氧化物歧化酶干燥失活的保护作用
RU2839164C1 (ru) Способ получения ферментолизата биомассы метанокисляющих бактерий
CN118547032A (zh) 降血脂蛋白水解物、肽及其制备方法和应用
WO2026082817A1 (en) Polypeptides having alkaline phosphatase activity for use in treatment of inflammatory and metabolic diseases